ISPE has announced official launch of its Metrics Pilot Program, which is headed by ISPE’s PQLI® Quality Metrics Team, and is now open to any drug manufacturing company that is registered with FDA. Primary objectives are to test harmonization of definitions for industry consensus metrics that represent both leading and lagging indicators, and to test feasibility of data collection across companies who are at different maturity levels with their own internal metrics programs.
This story is related to the following:Trade Associations